Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Circulating mir-208a fails as a biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients.

Literature DB >> 26046768

Circulating mir-208a fails as a biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients.

Vagner Oliveira-Carvalho¹, Ludmila Rodrigues Pinto Ferreira², Edimar Alcides Bocchi¹.

Abstract

Entities: Chemical Disease Gene Species

Keywords: Biomarker; Breast Cancer; Cardiotoxicity; Doxorubicin; microRNA

Mesh：

Substances：

Year: 2015 PMID： 26046768 DOI： 10.1002/jat.3185

Source DB: PubMed Journal: J Appl Toxicol ISSN： 0260-437X Impact factor: 3.446

Keyword Cloud
Cited

× No keyword cloud information.

15 in total

Review 1. Alternative Biomarkers for Combined Biology.

Authors: Yong-Hyun Kim; Jennifer Kirsop; Wai Hong Wilson Tang
Journal: Heart Fail Clin Date: 2017-04 Impact factor: 3.179

2. Creating a Biomarker Panel for Early Detection of Chemotherapy Related Cardiac Dysfunction in Breast Cancer Patients.

Authors: Krithika Srikanthan; Rebecca Klug; Maria Tirona; Ellen Thompson; Haresh Visweshwar; Nitin Puri; Joseph Shapiro; Komal Sodhi
Journal: J Clin Exp Cardiolog Date: 2017-03-22

Review 3. Improving cardiotoxicity prediction in cancer treatment: integration of conventional circulating biomarkers and novel exploratory tools.

Authors: Li Pang; Zhichao Liu; Feng Wei; Chengzhong Cai; Xi Yang
Journal: Arch Toxicol Date: 2020-11-21 Impact factor: 5.153

4. miR-140-5p mediates bevacizumab-induced cytotoxicity to cardiomyocytes by targeting the VEGFA/14-3-3γ signal pathway.

Authors: Xuan-Ying Chen; Wei-Lin Huang; Xiao-Ping Peng; Yan-Ni Lv; Jun-He Li; Jian-Ping Xiong
Journal: Toxicol Res (Camb) Date: 2019-09-05 Impact factor: 3.524

Review 5. Cardiotoxicity in HER2-positive breast cancer patients.

Authors: Diana Gonciar; Lucian Mocan; Alexandru Zlibut; Teodora Mocan; Lucia Agoston-Coldea
Journal: Heart Fail Rev Date: 2021-01-06 Impact factor: 4.214

Review 6. Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients.

Authors: Clarissa Ruggeri; Sonia Gioffré; Felice Achilli; Gualtiero I Colombo; Yuri D'Alessandra
Journal: Heart Fail Rev Date: 2018-01 Impact factor: 4.214

Circulating mir-208a fails as a biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients.

Review 1. Alternative Biomarkers for Combined Biology.

2. Creating a Biomarker Panel for Early Detection of Chemotherapy Related Cardiac Dysfunction in Breast Cancer Patients.

Review 3. Improving cardiotoxicity prediction in cancer treatment: integration of conventional circulating biomarkers and novel exploratory tools.

4. miR-140-5p mediates bevacizumab-induced cytotoxicity to cardiomyocytes by targeting the VEGFA/14-3-3γ signal pathway.

Review 5. Cardiotoxicity in HER2-positive breast cancer patients.

Review 6. Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients.

Review 7. Anthracycline induced cardiotoxicity: biomarkers and "Omics" technology in the era of patient specific care.

8. Comment on "MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction".

9. MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat.

Review 10. Protecting the heart in cancer therapy.